![Morgan Conn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Morgan Conn
No open positions remaining
Net worth: 163 278 $ as of 31/08/2026
Profile
Morgan Conn formerly worked at PTC Therapeutics, Inc., as Vice President-Business Development from 2001 to 2017, Amherst College, as Assistant Professor, Century Therapeutics, Inc., as Chief Financial Officer from 2024 to 2025, and Pharvaris NV, as Chief Business Officer from 2017 to 2024.
Dr. Conn received his doctorate degree from Massachusetts Institute of Technology and undergraduate degree from the University of Toronto.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/03/2025 | 79,648 ( 0.04% ) | 163 278 $ | 31/08/2026 |
Former positions of Morgan Conn
| Companies | Position | End |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Director of Finance/CFO | 11/07/2025 |
| PHARVARIS N.V. | Corporate Officer/Principal | 04/10/2024 |
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2017 |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Morgan Conn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Amherst College
Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharvaris NV
 Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
- Stock Market
- Insiders
- Morgan Conn
